First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic Neoplasms
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Luspatercept
Related studies linked through entity extraction aliases.
A Study of Luspatercept in People With Anemia
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Luspatercept Utilization in Patients With Lower Risk Myelodysplastic Syndromes or Beta-thalassemia
- Status
- TERMINATED
- Phase
- N/A
Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East
- Status
- RECRUITING
- Phase
- N/A
Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA
- Status
- WITHDRAWN
- Phase
- PHASE4
A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
- Status
- RECRUITING
- Phase
- PHASE2
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Status
- RECRUITING
- Phase
- PHASE2
Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
- Status
- RECRUITING
- Phase
- PHASE3